NORML

MARCH 30, 2020

They reported “circumstantial evidence” suggesting that CBD may possess antiviral acticity in a limited number of conditions, specifically in the treatment of hepatitis C and Karposi sarcoma. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 309

CBD Clinical Trials Data Treatment 309

Project CBD

FEBRUARY 1, 2023

For decades, researchers have studied cannabinoids’ ability to treat clinical skin conditions like acne, ulcers, and dermatitis. 3 It’s even possible that cannabinoids taken internally, and not simply via a localized topical, may be able to help — especially if a condition is more widespread. Suffice to say, they are thorough.

Conditions 130

Conditions THC CBD Cannabinoids 130

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 354

Patients Chronic Pain Treatment Therapy 354

NORML

JUNE 15, 2020

Late last week, the Governor signed House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 330

Access Patients Law Therapy 330

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 134

Treatment Cannabinoids Blood Pressure Patients 134

NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5

Chronic Pain 351

Chronic Pain Clinical Trials Data Patients 351

Greencamp

NOVEMBER 4, 2024

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that impacts millions worldwide. The post ADHD: Symptoms, Diagnostics and Alternative Treatment Options appeared first on Greencamp. Different Types.

Treatment 110

Treatment Conditions 110

MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. However, for many individuals, these conventional treatments may fall short of providing adequate relief or come with undesirable side effects.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 141

Treatment Research and Development Therapy Digestion 141

Medical Marijuana Pages

JANUARY 9, 2025

4 Health Conditions For Treatment by Medical Marijuana in Illinois. Has expanded the list of conditions eligible for medical cannabis treatment. In a significant development for patient care, the Illinois Department of Public Health.

Conditions 67

Conditions Treatment Marijuana Patients 67

LifeCannMD

JANUARY 31, 2025

Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.

Conditions 97

Conditions Research and Development Treatment Patients 97

NORML

MARCH 12, 2020

. “It is imperative that we approve legislation such as the Veterans Equal Access Act so that the countless vets suffering from post-traumatic stress and other debilitating disorders have access to the safe and effective option of medical marijuana treatment.” Blumenauer said, “Today was a monumental day for our veterans.

Marijuana 363

Marijuana Chronic Pain Policy Access 363

NORML

MARCH 14, 2019

Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Medical marijuana has shown proven benefits for treating these conditions denying our veterans access to them is shameful. Send a message now to your lawmakers.

Access 239

Access Chronic Pain Treatment Conditions 239

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105

Epilepsy Treatment Patients Strains 105

The Cannigma

OCTOBER 11, 2021

The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. who have used it to treat anxiety. Forty-percent of the respondents reported no adverse effect, and 84.3%

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

Veriheal

FEBRUARY 27, 2024

A new case study published this month by researchers at the Federal University of Santa Catarina in Brazil uncovered that cannabis could be a viable treatment for dogs with discoid lupus erythematosus (DLE), a common autoimmune skin disease in canines.

Conditions 110

Conditions Therapy Treatment CBD 110

Veriheal

JUNE 12, 2025

In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). However, doctors do not consider esketamine a first-line treatment for depression.

Therapy 69

Therapy Treatment Clinical Trials Blood Pressure 69

LifeCannMD

JULY 3, 2024

#image_title Medical Marijuana is becoming a widely used treatment for anxiety and mood disorders like PTSD (Post-Traumatic Stress Disorder). Fear Extinction: THC has been shown to facilitate the extinction of fear memories, a crucial process for PTSD treatment. Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

NORML

MARCH 11, 2020

I introduced the Veterans Equal Access Act, HR 1647 because it is my responsibility as a Member of Congress to ensure that all Americans have access to medical treatment as recommended by their physicians. Seeking care is hard enough, and we should not make it even harder for our veterans.

Chronic Pain 340

Chronic Pain Marijuana Access Treatment 340

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Epidiolex, a CBD-based medication, has even received FDA approval for the treatment of specific seizure disorders.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MMJ Recs

DECEMBER 30, 2023

For conditions like anxiety and PTSD, certain strains with higher CBD content may provide calming effects without the psychoactive properties associated with THC. The endocannabinoid system and mental health How does medical marijuana affect mood disorders and other mental health conditions?

Conditions 98

Conditions Marijuana Research and Development Treatment 98

NORML

JANUARY 6, 2023

“Cannabis has established efficacy in the treatment of multiple conditions, including chronic pain, and it possesses a safety profile that is either comparable or superior to other controlled substances.

Chronic Pain 229

Chronic Pain Patients Safety Treatment 229

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 275

Clinical Trials Chronic Pain Cannabinoids Patients 275

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 211

Clinical Trials Chronic Pain Data Treatment 211

NORML

JUNE 18, 2019

Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.” “In the present study, we demonstrated that medical cannabis is an effective and safe option for the treatment of fibromyalgia patients’ symptoms,” authors concluded.

Patients 279

Patients Therapy Data Safety 279

Project CBD

APRIL 26, 2023

He had never taken anti-psychotic drugs nor received psychological treatment. Due to its excellent tolerability and promising efficacy … and its innovative new mechanisms of action, we decided to offer a respective treatment with cannabidiol to [the] patient,” they write. Cannabidiol as a potential treatment for psychosis.”

CBD 296

CBD Treatment Cannabinoids Medicine 296

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us.

Access 238

Access Marijuana Treatment Legislation 238

LifeCannMD

MARCH 31, 2025

At LifeCannMD, under the expert guidance of Dr. Fernando Fandino-Sende – Miami’s Top Cannabis Doctor, we understand that seeking medical cannabis treatment is more than a clinical decisionit’s a deeply personal journey toward wellness, often undertaken after considerable reflection and other failed interventions.

Treatment 80

Treatment Chronic Pain History Conditions 80

Project CBD

JANUARY 24, 2019

In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment.

Research and Development 258

Research and Development Chronic Pain Cannabinoids Treatment 258

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 239

Legislation Access Chronic Pain Marijuana 239

NORML

APRIL 30, 2019

A poll commissioned by the American Legion showed that more than 1 in 5 veterans self-reported using marijuana to alleviate a medical or physical condition. Join me in sending a message to Congress now in support of veterans healthcare rights.

Access 253

Access Legislation Chronic Pain Treatment 253

NORML

JUNE 10, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5

Chronic Pain 258

Chronic Pain Therapy Patients Topical 258

Veriheal

JULY 18, 2023

Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE). Together, these efforts mark a promising shift towards a more science-driven approach to policy-making in mental health treatment.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

NORML

JUNE 1, 2020

On Sunday, legislators finalized HB 819 , which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 215

Access Therapy Legislation Patients 215

NORML

JANUARY 24, 2019

With the opioid crisis raging across America, it is imperative to the health and safety of our veterans that we find alternative treatments for chronic pain and service-related injuries.” Furthermore, twenty-two percent of respondents said they themselves “use cannabis to treat a mental or physical condition.”

Legislation 232

Legislation Chronic Pain Safety Medicine 232

Project CBD

JUNE 20, 2023

Food and Drug Administration, three are prescribed for the treatment of chemotherapy-induced nausea and vomiting. One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). But gastrointestinal symptoms, such as nausea and upset stomach, aren’t far behind.

Cannabinoids 215

Cannabinoids Patients Treatment Conditions 215

LifeCannMD

MARCH 3, 2025

Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. This gives us another way to think about treating the condition.

Research and Development 52

Research and Development Treatment Conditions Patients 52